Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer J Knox

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Addressing the interplay of liver disease and hepatocellular carcinoma on patient survival: the ALBI scoring modelJennifer J Knox
Lancet (London, England)|July 26, 2008
Progression-free survival as endpoint in metastatic RCC?Jennifer J Knox
The Oncologist|December 11, 2012
Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continuesAndrew X Zhu, Jennifer J Knox
Chinese Clinical Oncology|October 6, 2016
Adjuvant therapy for resected biliary tract cancer: a reviewMark K Doherty, Jennifer J Knox
Hepatic Oncology|September 8, 2018
Systemic therapy for hepatocellular carcinomaMairéad G McNamara, Jennifer J Knox
Journal of Oncology Practice|December 12, 2018
Adjuvant Therapy for Biliary Tract CancersAnne M Horgan, Jennifer J Knox
Current Problems in Cancer|November 21, 2017
Locally advanced pancreatic cancer: An emerging entityGrainne M O Kane, Jennifer J Knox
Hematology/Oncology Clinics of North America|June 17, 2026
Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and ImmunotherapyRonan McLaughlin, Harry Harvey, Jennifer J Knox
Journal of Clinical and Experimental Hepatology|May 20, 2024
A Case of First-line Atezolizumab Plus Bevacizumab Use in Recurrence of Combined Hepatocellular Cholangiocarcinoma After Surgical ResectionGordon T Moffat, Kai Duan, Jennifer J Knox
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 12, 2020
Severe optic neuropathy as the presenting sign of leptomeningeal carcinomatosis from pancreatic cancerArmin Farahvash, Jennifer J Knox, Jonathan A Micieli
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Addressing the interplay of liver disease and hepatocellular carcinoma on patient survival: the ALBI scoring modelJennifer J Knox
Lancet (London, England)|July 26, 2008
Progression-free survival as endpoint in metastatic RCC?Jennifer J Knox
The Oncologist|December 11, 2012
Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continuesAndrew X Zhu, Jennifer J Knox
Chinese Clinical Oncology|October 6, 2016
Adjuvant therapy for resected biliary tract cancer: a reviewMark K Doherty, Jennifer J Knox
Hepatic Oncology|September 8, 2018
Systemic therapy for hepatocellular carcinomaMairéad G McNamara, Jennifer J Knox
Journal of Oncology Practice|December 12, 2018
Adjuvant Therapy for Biliary Tract CancersAnne M Horgan, Jennifer J Knox
Current Problems in Cancer|November 21, 2017
Locally advanced pancreatic cancer: An emerging entityGrainne M O Kane, Jennifer J Knox
Hematology/Oncology Clinics of North America|June 17, 2026
Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and ImmunotherapyRonan McLaughlin, Harry Harvey, Jennifer J Knox
Journal of Clinical and Experimental Hepatology|May 20, 2024
A Case of First-line Atezolizumab Plus Bevacizumab Use in Recurrence of Combined Hepatocellular Cholangiocarcinoma After Surgical ResectionGordon T Moffat, Kai Duan, Jennifer J Knox
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 12, 2020
Severe optic neuropathy as the presenting sign of leptomeningeal carcinomatosis from pancreatic cancerArmin Farahvash, Jennifer J Knox, Jonathan A Micieli
Pageof 20